Evidence map›Paper›PMID 31620280›Full record

ArticleMolecular and clinical oncology2019

Goblet cell carcinoid of the appendix: Two case reports and a review of the literature.

Alejandro Livoff, Noam Asna, Enrique Gallego-Colon, Aner Zeev Daum, Tattiana Harkovsky, Moshe Schaffer

Erratum issuedAbstract read
In one paragraph

Article in Molecular and clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alejandro LivoffDepartment of Pathology, Barzilai Medical Center, Ashkelon 30604, Israel.
Noam AsnaDepartment of Oncology, Barzilai Medical Center, Ashkelon 30604, Israel.
Enrique Gallego-ColonDepartment of Pathology, Barzilai Medical Center, Ashkelon 30604, Israel.
Aner Zeev DaumDepartment of Pathology, Barzilai Medical Center, Ashkelon 30604, Israel.
Tattiana HarkovskyDepartment of Oncology, Barzilai Medical Center, Ashkelon 30604, Israel.
Moshe SchafferDepartment of Oncology, Barzilai Medical Center, Ashkelon 30604, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Goblet cell carcinoid or carcinoma (GCC) is a rare tumor found incidentally during routine management of acute appendicitis. GCCs are more aggressive compared with conventional appendiceal tumors but less aggressive compared with adenocarcinomas, and they often present with serosal and mesoappendiceal involvement. We herein report two cases of acute appendicitis in a 45-year-old female and a 60-year-old male with varied clinical symptoms. Pathological examination of the appendix revealed the presence of adenocarcinoma with goblet cells and a Ki-67 index of 25% (grade 3) and 15% (grade 2), respectively. Subsequent right hemicolectomy was performed according to the current guidelines. No signs of disease recurrence or metastasis were detected during regular follow-up. However, the lack of a standardized classification system for GCC and the discrepancies in specific reliable markers renders their prognostic and predictive value in GCC at diagnosis insufficient. The present study also aimed to address current concerns regarding the diagnosis, treatment and prognosis of GCC, as well as the need to review and update current guidelines. To conclude, proper clinical management and the prediction of outcome for patients with GCC varies according to the classifications or staging criteria used by the clinicians; hence, a review of the current guidelines should be considered.

Indexed as

appendicular carcinoidappendicular tumorcase reportgoblet cell carcinoidguidelinesneuroendocrine tumorprognosis

Identifiers

PMID31620280
PMCPMC6787945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.